10 completed, 7 unknown, 5 recruiting, 1 not yet recruiting. 25 Phase 2, 6 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 25 | Completed 10, Unknown 7, Recruiting 5, Not yet recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 1 | 6 | Recruiting 4, Completed 2 |
| Phase 3 | 3 | Completed 2, Unknown 1 |
Follow TMS: new trials by email Literature Review of TMS trials Research Report on TMS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies Transcranial Magnetic Stimulation, Psilocybin (drug), Neurofeedback - PTSD, PTSD - Post Traumatic Stress Disorder | Phase 2 | Not yet recruiting | University of New Mexico | 150 | 2026-12-31 | 2026-10-30 |
| Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder Sham iTBS, TMS, D-cycloserine - Major Depression, Healthy Participants | Phase 1 / Phase 2 | Recruiting | Mclean Hospital | 100 | 2026-10-01 | 2026-10-30 |
| A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality Disorder TMS, D-Cycloserine (DCS) - Borderline Personality Disorder (BPD) | Phase 1 / Phase 2 | Recruiting | Mclean Hospital | 20 | 2026-06-10 | 2026-08-05 |
| Dual-target iTBS for Youth With ADHD TMS - ADHD | Phase 1 / Phase 2 | Recruiting | Shanghai Mental Health Center | 15 | 2025-01-01 | 2025-07-24 |
| Neuromodulation of the Hippocampus to Reduce Intrusive Re-Experiencing in PTSD: A Randomized Controlled Trial Hippocampal stimulation using repetitive transcranial magnetic stimulation (rTMS), Sham stimulation using repetitive transcranial magnetic stimulation (rTMS) - PTSD - Post Traumatic Stress Disorder, Intrusive Memories of Traumatic Event(s) | Phase 2 | Recruiting | Tel Aviv University | 60 | 2024-11-01 | 2024-11-01 |
| Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD) TMS, Transcranial Magnetic Stimulation Sham - Alzheimer&Amp;Amp;#39;s Disease, Alzheimer Disease | Phase 1 / Phase 2 | Recruiting | University of California, Los Angeles | 54 | 2024-10-17 | 2026-09-04 |
| Individualized Functional Connectivity Targeting in aiTBS for Depression transcranial magnetic stimulation - Depressive Disorder, Major, Depression | Phase 2 | Completed | Brigham and Women's Hospital | 40 | 2023-07-15 | 2026-08-25 |
| Symptom-specific TMS Targets for Depression and Anxiety Transcranial magnetic stimulation - Depression, Anxiety | Phase 2 | Completed | Brigham and Women's Hospital | 40 | 2021-02-03 | 2024-08-01 |
| Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial Lopinavir/Ritonavir 200 MG-50 MG Oral Tablet, Telmisartan 40Mg Oral Tablet, Atorvastatin 20 Mg Oral Tablet - COVID-19, COVID-19 Drug Treatment | Phase 2 / Phase 3 | Completed | ANRS, Emerging Infectious Diseases | 294 | 2020-11-27 | 2024-12-27 |
| RTMS for Treatment of Pain and Craving Real Transcranial Magnetic Stimulation, Sham Transcranial Magnetic Stimulation - Pain, Chronic, Pain Acute | Phase 2 | Completed | Medical University of South Carolina | 22 | 2017-07-06 | 2024-09-19 |
| Repetitive Transcranial Magnetic Stimulation Associated With Manual Therapy in Knee Ostearthritis Pain TMS, Manual therapy (MT) - Knee Osteoarthritis | Phase 2 | Unknown | Universidade Federal de Pernambuco | 15 | 2017-01-01 | 2017-03-10 |
| Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Rituximab, Conditioning chemotherapy, TMS - Myelodysplastic Syndromes, Hodgkin's Lymphoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 34 | 2015-09-24 | 2025-09-30 |
| TMS Electrochemotherapy for Glioblastoma Multiforme TMS - Glioblastoma | Phase 2 | Withdrawn | University of Aarhus | 2015-01-01 | 2021-09-20 | |
| Towards Individualized Deep Brain Stimulation Treatment of Chronic Neuropathic Pain Deep brain stimulation, Cervel Neurotech, Multi-coil TMS, 11C-Carfentanil - Neuralgia | Phase 2 | Terminated | University of Aarhus | 3 | 2014-04-01 | 2021-09-14 |
| Repetitive Transcranial Magnetic Stimulation and Intermittent Theta Burst (iTBS) in Schizophrenia repetitive Transcranial Magnetic Stimulation (Magstim rapid2 ), repetitive Transcranial Magnetic Stimulation (Magstim rapid2), repetitive Transcranial Magnetic Stimulation(Magstim rapid2) - Schizophrenia | Phase 2 | Unknown | University of Tehran | 30 | 2011-01-01 | 2015-09-01 |
| Effects of Repeated Transcranial Magnetic Stimulation (rTMS) on the Treatment of Cocaine Addicted Patients Transcranial Magnetic Stimulation - Cocaine Addiction, Treatment | Phase 2 | Unknown | University of Sao Paulo General Hospital | 40 | 2010-03-01 | 2010-12-22 |
| Repetitive Transcranial Magnetic Stimulation in Symptoms of Attention Deficit Hyperactivity Disorder and Cognitive Function In Cocaine Addicts repetitive Transcranial Magnetic Stimulation (rTMS) - Cognition Disorders, Cocaine Dependence | Phase 2 | Unknown | University of Sao Paulo General Hospital | 40 | 2010-03-01 | 2012-05-23 |
| Study of the Effect of Magnetic Stimulation Repetitive Transcranial on Impulsivity in Cocaine Dependence Transcranial Magnetic Stimulation, Placebo TMS - Cocaine Dependence | Phase 2 | Unknown | University of Sao Paulo General Hospital | 20 | 2010-03-01 | 2011-07-19 |
| rTMS in Elderly Depressed:Neuronavegated Study Transcranial Magnetic Stimulation, Repetitive Transcranial Magnetic Stimulation - DEPRESSION | Phase 2 | Unknown | University of Sao Paulo General Hospital | 40 | 2009-08-01 | 2011-06-30 |
| Evaluation of the H-Coil Transcranial Magnetic Stimulation(TMS) Device- Augmentation for Drug Resistant Depression TMS - Major Depression | Phase 2 | Completed | BeerYaakov Mental Health Center | 40 | 2008-01-01 | 2009-10-06 |
Showing 20 of 25. Sign in to see all of them.
Depression (6) · Depressive Disorder, Major (6) · Cocaine-Related Disorders (3) · Attention Deficit Disorder with Hyperactivity (2) · Chronic Pain (2) · Combat Disorders (2) · Hodgkin Disease (2) · Leukemia (2) · Lymphoma (2) · Multiple Myeloma (2) · Myelodysplastic Syndromes (2) · Stress Disorders, Post-Traumatic (2) · Acute Pain (1) · Alzheimer Disease (1) · Anxiety Disorders (1)
University of Sao Paulo General Hospital (6) · Brigham and Women's Hospital (2) · Mclean Hospital (2) · Medical University of South Carolina (2) · National Cancer Institute (NCI) (2) · University of Aarhus (2) · ANRS, Emerging Infectious Diseases (1) · BeerYaakov Mental Health Center (1) · Centre hospitalier de Ville-Evrard, France (1) · Shanghai Mental Health Center (1) · Tel Aviv University (1) · Universidade Federal de Pernambuco (1) · University of California, Los Angeles (1) · University of New Mexico (1) · University of Tehran (1)
United States (9) · Brazil (6) · Israel (2) · China (1) · Côte d’Ivoire (1) · Denmark (1) · France (1) · Iran (1)
Adan Jardim (1) · Alain Mina, M.D. (1) · Bianca B. Bellini (1) · Carlos G Mansur, MD (1) · Colleen A Hanlon, PhD (1) · Davin Quinn, MD (1) · Debora Arnaut, PSYD (1) · Jenna M Traynor, PhD (1) · Joseph J Taylor, MD, PhD (1) · Joshua Brown, MD, PhD (1) · Joshua C Brown, MD, PhD (1) · Mark S. George, MD (1)
PMID 20439832, PMID 21557884, PMID 23769413, PMID 32785680, PMID 38669315, PMID 39443527, PMID 40065917, PMID 40331908, PMID 41912790, PMID 42340706
K23AG097987 (1), R01MH069887 (1)